1 |
Guixé-Muntet S, Quesada-Vázquez S, Gracia-Sancho J. Pathophysiology and therapeutic options for cirrhotic portal hypertension[J]. Lancet Gastroenterol Hepatol, 2024, 9(7): 646-663.
|
2 |
Kaur H, Premkumar M. Diagnosis and management of cirrhotic cardiomyopathy[J]. J Clin Exp Hepatol, 2022, 12(1): 186-199.
|
3 |
Huang DQ, Terrault NA, Tacke F, et al. Global epidemiology of cirrhosis-aetiology, trends and predictions[J]. Nat Rev Gastroenterol Hepatol, 2023, 20(6): 388-398.
|
4 |
Russell K, Eriksen M, Aaberge L, et al. A novel clinical method for quantification of regional left ventricular pressure–strain loop area: a non-invasive index of myocardial work[J]. Eur Heart J, 2012, 33(6): 724-733.
|
5 |
Lim TS, Kim JK. Is liver biopsy still useful in the era of non-invasive tests?[J]. Clin Mol Hepatol, 2020, 26(3): 302-304.
|
6 |
Sugimoto K, Moriyasu F, Oshiro H, et al. The role of multiparametric US of the liver for the evaluation of nonalcoholic steatohepatitis[J]. Radiology, 2020, 296(3): 532-540.
|
7 |
李沁园, 董常峰, 冯程, 等.基于弹性成像多模态法评估慢性乙型肝炎肝纤维化程度[J/OL].中华医学超声杂志(电子版), 2022, 19(9): 976-982.
|
8 |
Sigrist RMS, Liau J, Kaffas AE, et al. Ultrasound elastography: review of techniques and clinical applications[J]. Theranostics, 2017, 7(5): 1303-1329.
|
9 |
Chen SH, Li YF, Lai HC, et al. Effects of patient factors on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in patients with chronic hepatitis C[J]. BMC Gastroenterol, 2012, 12: 105.
|
10 |
Liu H, Li H, Deng G, et al. Association of AST/ALT ratio with 90-day outcomes in patients with acute exacerbation of chronic liver disease: a prospective multicenter cohort study in China[J]. Front Med, 2024, 11: 1307901.
|
11 |
Vitek L, Hinds TD, Stec DE, et al. The physiology of bilirubin: health and disease equilibrium[J]. Trends Mol Med, 2023, 29(4): 315-328.
|
12 |
中华医学会肝病学分会, 中华医学会消化病学分会. 终末期肝病临床营养指南[J].中华肝脏病杂志, 2019, 27(5): 330-342.
|
13 |
Tandon P, Montano-Loza AJ, Lai JC, et al. Sarcopenia and frailty in decompensated cirrhosis[J]. J Hepatol, 2021, 75(Suppl 1): S147-S162.
|
14 |
Almeida F, Sousa A. Cirrhotic cardiomyopathy: Pathogenesis, clinical features, diagnosis, treatment and prognosis[J]. Rev Port Cardiol, 2024, 43(4): 203-212.
|
15 |
Lee SK, Song MJ, Kim SH, et al. Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis[J]. Clin Mol Hepatol, 2018, 24(4): 409-416.
|
16 |
Dourakis SP, Geladari E, Geladari C, et al. Cirrhotic cardiomyopathy: The interplay between liver and cardiac muscle. How does the cardiovascular system react when the liver is diseased?[J]. Curr Cardiol Rev, 2021, 17(1): 78-84.
|
17 |
Dimitroglou Y, Aggeli C, Alexopoulou A, et al. The contemporary role of speckle tracking echocardiography in cirrhotic cardiomyopathy[J]. Life(Basel), 2024, 14(2): 179.
|
18 |
陈相林, 丁珺, 程翅, 等.交感神经系统在肝硬化及其并发症中的作用研究进展[J].中国医学科学院学报, 2024, 46(1): 128-134.
|
19 |
Han X, Shi Q, Tu Y, et al. Cardiomyocyte PRL2 promotes cardiac hypertrophy via directly dephosphorylating AMPKα2[J]. Circ Res, 2025, 136(7): 645-663.
|
20 |
Dekleva M, Lazic JS, Soldatovic I, et al. Improvement of ventricular-arterial coupling in elderly patients with heart failure after beta blocker therapy: results from the CIBIS-ELD Trial[J]. Cardiovasc Drugs Ther, 2015, 29(3): 287-294.
|
21 |
Wang WT, Wu TH, Er LK, et al. Recent progress in unraveling cardiovascular complications associated with primary aldosteronism: a succinct review[J]. Hypertens Res, 2024, 47(5): 1103-1119.
|
22 |
Varghese TP, Tazneem B. Unraveling the complex pathophysiology of heart failure: insights into the role of renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system (SNS)[J]. Curr Probl Cardiol, 2024, 49(4): 102411.
|
23 |
Baldassarre M, Giannone FA, Napoli L, et al. The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives[J]. Liver Int, 2013, 33(9): 1298-1308.
|